insights_auto
Why is 22UA down 5.54%?
Dive Deeperchevron_right
22UA:FRA
BioNTech SE - ADR
€81.05
arrow_downward
-5.54%(-4.75) 1D
Oct 13, 1:41:41 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 22UA...
Open
€85.45
High
€85.45
Low
€80.00
Mkt. cap
24.08B
Avg. vol.
1.30K
Volume
1.49K
52-wk high
€105.50
52-wk low
€68.00
No. of employees
8K
Open
€85.45
High
€85.45
Low
€80.00
Mkt. cap
24.08B
Avg. vol.
1.30K
Volume
1.49K
52-wk high
€105.50
52-wk low
€68.00
No. of employees
8K
News stories
From web sources and news partners
Benzinga
·
1 hour ago
Syndax Pharmaceuticals, BioNTech, Seagate And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
Investing.com
·
1 hour ago
Why is BioNTech stock sliding today?
Investing.com
·
1 hour ago
BioNTech stock falls after cancer trial misses key endpoint
TipRanks
·
1 hour ago
BioNTech Stock Slumps After Key Cancer Trial Disappoints
Profile
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes.
In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic. Wikipedia
About BioNTech SE - ADR